Find Taurine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Australia

Australia

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

6RELATED EXCIPIENT COMPANIES

10EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2-aminoethanesulfonic acid, 107-35-7, Ethanesulfonic acid, 2-amino-, L-taurine, Tauphon, 2-aminoethylsulfonic acid
Molecular Formula
C2H7NO3S
Molecular Weight
125.15  g/mol
InChI Key
XOAAWQZATWQOTB-UHFFFAOYSA-N
FDA UNII
1EQV5MLY3D

Taurine
A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.
1 2D Structure

Taurine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-aminoethanesulfonic acid
2.1.2 InChI
InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)
2.1.3 InChI Key
XOAAWQZATWQOTB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(CS(=O)(=O)O)N
2.2 Other Identifiers
2.2.1 UNII
1EQV5MLY3D
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Taufon

2. Tauphon

3. Taurine Hydrochloride

4. Taurine Zinc Salt (2:1)

5. Taurine, Monopotassium Salt

2.3.2 Depositor-Supplied Synonyms

1. 2-aminoethanesulfonic Acid

2. 107-35-7

3. Ethanesulfonic Acid, 2-amino-

4. L-taurine

5. Tauphon

6. 2-aminoethylsulfonic Acid

7. 2-sulfoethylamine

8. 2-aminoethane-1-sulfonic Acid

9. O-due

10. Aminoethylsulfonic Acid

11. Taufon

12. Aminoethanesulfonic Acid

13. Beta-aminoethylsulfonic Acid

14. Taurinum [latin]

15. Taurina [spanish]

16. Fema No. 3813

17. Taurine [inn]

18. Ccris 4721

19. Nci-c60606

20. Ai3-18307

21. Nsc32428

22. Nsc-32428

23. 1eqv5mly3d

24. 2-aminoethane Sulfonic Acid

25. .beta.-aminoethylsulfonic Acid

26. 1-aminoethane-2-sulfonic Acid

27. Chebi:15891

28. Ncgc00015997-06

29. Dsstox_cid_1304

30. Dsstox_rid_76069

31. Dsstox_gsid_21304

32. Aminoethylsulfonic Acid (jan)

33. Taurine Hydrochloride

34. 2-amino-ethanesulfonic Acid

35. Taurina

36. Taurinum

37. Aminoethylsulfonic Acid [jan]

38. Cas-107-35-7

39. Smr000326743

40. Sr-01000076144

41. 2-aminoethanesulfonicacid

42. Einecs 203-483-8

43. Unii-1eqv5mly3d

44. Nsc 32428

45. Taurine [usp:inn:ban]

46. Taurineold

47. Taukard

48. Taurate

49. Hsdb 8167

50. Aminoethylsulfonate

51. Taurine,(s)

52. Taurine (tn)

53. B-aminoethylsulfonate

54. Mfcd00008197

55. Taurine (8ci)

56. 2-aminoethylsulfonate

57. 2-aminoethyl Sulfonate

58. Beta-aminoethylsulfonate

59. Taurine-[13c2]

60. Tocris-0209

61. Taurine [vandf]

62. 2aminoethanesulfonic Acid

63. Taurine [fhfi]

64. Taurine [inci]

65. Taurine, >=99%

66. B-aminoethylsulfonic Acid

67. Taurine [jan]

68. Taurine [mi]

69. Taurine [mart.]

70. Lopac-t-0625

71. Taurine [usp-rs]

72. Taurine [who-dd]

73. Wln: Z2swq

74. 1-aminoethane-2-sulfonate

75. Bmse000120

76. Bmse000805

77. Bmse000863

78. Ec 203-483-8

79. 2-aminoethanesulfonic Acid.

80. Lopac0_001134

81. Schembl23068

82. Taurine, >=98%, Fg

83. Mls000859681

84. Mls001332383

85. Mls001332384

86. Taurine (jp17/usp/inn)

87. Chembl239243

88. Gtpl2379

89. Taurine [usp Monograph]

90. Dtxsid3021304

91. Taurine, >=99.0% (t)

92. Hms2093l13

93. Hms2233d19

94. Hms3263d09

95. Hms3370j18

96. Pharmakon1600-01505463

97. Hy-b0351

98. Rkl10149

99. Taurine; 2-aminoethanesulfonic Acid

100. Zinc3809490

101. Tox21_110277

102. Tox21_202520

103. Tox21_501134

104. Bdbm50357220

105. Nsc759150

106. S2008

107. Stl197941

108. Akos005208848

109. Tox21_110277_1

110. Ccg-205208

111. Db01956

112. Ethanesulfonic Acid, 2-amino- (9ci)

113. Lp01134

114. Nsc-759150

115. Sdccgsbi-0051101.p003

116. Taurine, Bioultra, >=99.5% (t)

117. Taurine, Saj First Grade, >=98.5%

118. Ncgc00015997-01

119. Ncgc00015997-02

120. Ncgc00015997-03

121. Ncgc00015997-04

122. Ncgc00015997-05

123. Ncgc00015997-07

124. Ncgc00015997-08

125. Ncgc00015997-10

126. Ncgc00015997-20

127. Ncgc00024497-01

128. Ncgc00024497-02

129. Ncgc00024497-03

130. Ncgc00024497-04

131. Ncgc00024497-05

132. Ncgc00260069-01

133. Ncgc00261819-01

134. As-13587

135. Nci60_002814

136. Sbi-0051101.p002

137. Taurine, Vetec(tm) Reagent Grade, >=99%

138. A0295

139. Am20080018

140. B1846

141. Eu-0101134

142. Ft-0611241

143. T-130

144. C00245

145. D00047

146. D78121

147. T 0625

148. Ab00443712-07

149. Ab00443712_09

150. Ab00443712_10

151. Q207051

152. J-508042

153. Sr-01000076144-1

154. Sr-01000076144-3

155. Sr-01000076144-5

156. Taurine, Certified Reference Material, Tracecert(r)

157. F2191-0280

158. Z1317839154

159. Taurine, Cell Culture Tested, Meets Usp Testing Specifications

160. Taurine, United States Pharmacopeia (usp) Reference Standard

161. Taurine, Pharmaceutical Secondary Standard; Certified Reference Material

162. Taurine, Pharmagrade, Ajinomoto, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production, Suitable For Cell Culture

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 125.15 g/mol
Molecular Formula C2H7NO3S
XLogP3-4.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass125.01466426 g/mol
Monoisotopic Mass125.01466426 g/mol
Topological Polar Surface Area88.8 Ų
Heavy Atom Count7
Formal Charge0
Complexity120
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Taurine may be helpful in some with congestive heart failure and hypertension. It has demonstrated some antiatherogenic effects in both animal and human studies.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 607


THERAPEUTIC CATEGORY (VETERINARY): In preventation of retinal degeneration and in prevention and treatment of taurine-deficiency cardiomyopathy in cats

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK: Royal Society of Chemistry, 2013., p. 1679


Taurine has been added to most human infant formulas since the mid-1980s.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 607


4.2 Drug Warning

Pregnant women and nursing mothers should avoid taurine supplements unless recommended by their physicians. Those with congestive heart failure should only use taurine under medical supervision.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 609


Taurine is contraindicated in those hypersensitive to any component of a taurine-containing nutritional supplement.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 609


4.3 Drug Indication

The use of diet supplements containing taurine is indicated for the nutritional support of infants and young pediatric patients requiring total parenteral nutrition via central or peripheral routes. The usage of diet supplements containing taurine prevents nitrogen and weight loss or to treat negative nitrogen balance in pediatric patients where the alimentary tract cannot be done through oral, gastrostomy or jejunostomy administration, there is impaired gastrointestinal absorption or protein requirements are substantially increased.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

The diet supplements containing taurine are formulated as a well-tolerated nitrogen source for nutritional support. Administration of diet supplements regulates the level of plasma amino acid concentration, nitrogen balance, weight and serum protein concentration to reach normal values, thus improving the nutritional status.


5.2 Absorption, Distribution and Excretion

Absorption

Oral administration of taurine was studied and it reported dose-dependent values of AUC, Cmax and tmax wherein a dose of 1-30 mg/kg ranged from 89-3452 mcg min/L, 2-15.7 mcg min/ml and 15 min respectively. Further studies in healthy individuals gave an AUC, Cmax and tmax in the range of 116-284.5 mg h/L, 59-112.6 mg/L and 1-2.5 h.


Route of Elimination

Taurine flows and gets distributed in veins and arteries and reports have observed the presence of a significant released of taurine in portally drained viscera, thus suggesting that the main elimination route of taurine is by the gut. This elimination route may be explained by the enterohepatic cycle of taurine.


Volume of Distribution

The distribution of taurine was studied under the two-compartment model and each one of the compartments gave a range for the volume of distribution of 299-353 ml/kg in compartment 1 and 4608-8374 ml/kg in compartment 2 in mice. Further studies in healthy indivudals gave a volume of distribution that ranged from 19.8 to 40.7 L.


Clearance

The clearance rate of orally administered taurine was reported to be dose-dependent wherein a dose of 1 mg/kg it presents a clearance rate of 11.7 ml min/kg, 10 mg/kg generates a clearance rate of 18.7 ml min/kg and a dose of 30 mg/kg reports a clearance rate of 9.4 ml min/kg. Further studies in healthy individuals generate a clearance rate that ranged from 14 to 34.4 L/h.


Taurine is not usually completely reabsorbed from the kidneys, and some fraction of an ingested dose of taurine is excreted in the urine.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 608


Following ingestion, taurine is absorbed from the small intestine via the beta-amino acid or taurine transport system... Tautine is transported to the liver via the portal circulation, where much of it forms conjugates with bile acids... The taurine conjugates are excreted via the biliary route. Taurine that is not conjugated in the liver is distributed via the systemic circulation to various tissues in the body.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 608


Taurine is present in high amounts in the brain, retina, myocardium, skeletal and smoth muscle, platelets and neutrophils.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 607


Human studies showed significant increases in plasma taurine 90 minutes after consumption of a taurine-rich meal with levels declining to background within 180-270 minutes...

European Food Safety Authority (EFSA); EFSA Journal 935: 1-31 (2009). Available from, as of August 19, 2014: https://www.efsa.europa.eu/en/efsajournal/doc/935.pdf


For more Absorption, Distribution and Excretion (Complete) data for Taurine (7 total), please visit the HSDB record page.


5.3 Metabolism/Metabolites

Taurine can be metabolized by diverse organisms to form different types of metabolites derived from the original form of taurine. In the human, the pathways that form the metabolism of taurine are divided in the formation of 5-glutamyl-taurine by the action of the enzyme gamma-glutamyltransferase 6 or the formation of taurocholate by the action of the bile acid-CoA:amino acid N-acyltransferase.


There are two sources of taurine in the body: dietary and endogenous. In mammals, taurine is synthesised in many tissues; the main sites are liver, brain and pancreas, predominantly in alpha-islets. Taurine is synthesised from cysteine and methionine in a few steps, one of which requires pyridoxal-5-phosphate (vitamin B6) as coenzyme of cysteine sulphinate decarboxylase. In species other than mammals, the biosynthesis of taurine has been poorly studied. The extent of synthesis varies widely between species. An adult rat consuming standard laboratory food produces about 80 % of its total body taurine and obtains the remainder from the diet. However, if required, rats can obtain all body taurine from biosynthesis, since rats fed taurine-free diets for extended periods do not exhibit any decrease in tissue taurine concentrations. Cats have low levels of activity of cysteine sulphinate decarboxylase, the rate-limiting enzyme for taurine biosynthesis, and are, therefore, dependent on a dietary source to maintain their body pool of this amino acid. Thus, taurine is an essential nutrient in cats.

European Food Safety Authority (EFSA); EFSA Journal 10 (6): 2736 (2012). Available from, as of August 19, 2014: https://www.efsa.europa.eu/en/efsajournal/doc/2736.pdf


Taurocholate, the bile salt conjugate of taurine and cholic acid, is the principal conjugate formed via the action of the enzyme choloyl-CoA N-acyltransferase.

PDR for Nutritional Supplements 2nd ed. Thomson Reuters, Montvale, NJ 2008, p. 608


In all vertebrates except mammals, taurine is the sole amino acid conjugated to form bile salts. Among the mammals, carnivores also tend to be conjugators of taurine only, whereas other species tend to conjugate both taurine and glycine. High concentrations of taurine are present in retina, liver, pancreas, central nervous system and white blood cells. The largest pools of taurine are found in skeletal and cardiac muscles, where it regulates intracellular Ca2+ concentration...

European Food Safety Authority (EFSA); EFSA Journal 10 (6): 2736 (2012). Available from, as of August 19, 2014: https://www.efsa.europa.eu/en/efsajournal/doc/2736.pdf


5.4 Biological Half-Life

Oral administration of taurine in healthy individuals gave a plasma elimination half-life that ranged from 0.7-1.4 h.


5.5 Mechanism of Action

The diet supplements containing taurine function by replacing the missing nutriments in the body. Taurine, as a single agent, presents different functions like substrate for formation of bile salts, cell volume regulation, modulation of intracellular calcium, cytoprotection of central nervous system, etc.


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Topical

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ANALYTICAL

Upload your methods for free, ask us

Analytical Methods

read-more
read-more

ABOUT THIS PAGE

Looking for 107-35-7 / Taurine API manufacturers, exporters & distributors?

Taurine manufacturers, exporters & distributors 1

96

PharmaCompass offers a list of Taurine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Taurine manufacturer or Taurine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Taurine manufacturer or Taurine supplier.

PharmaCompass also assists you with knowing the Taurine API Price utilized in the formulation of products. Taurine API Price is not always fixed or binding as the Taurine Price is obtained through a variety of data sources. The Taurine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Taurine

Synonyms

2-aminoethanesulfonic acid, 107-35-7, Ethanesulfonic acid, 2-amino-, L-taurine, Tauphon, 2-aminoethylsulfonic acid

Cas Number

107-35-7

Unique Ingredient Identifier (UNII)

1EQV5MLY3D

About Taurine

A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.

1-Aminoethane-2-sulfonate Manufacturers

A 1-Aminoethane-2-sulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-Aminoethane-2-sulfonate, including repackagers and relabelers. The FDA regulates 1-Aminoethane-2-sulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-Aminoethane-2-sulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 1-Aminoethane-2-sulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

1-Aminoethane-2-sulfonate Suppliers

A 1-Aminoethane-2-sulfonate supplier is an individual or a company that provides 1-Aminoethane-2-sulfonate active pharmaceutical ingredient (API) or 1-Aminoethane-2-sulfonate finished formulations upon request. The 1-Aminoethane-2-sulfonate suppliers may include 1-Aminoethane-2-sulfonate API manufacturers, exporters, distributors and traders.

click here to find a list of 1-Aminoethane-2-sulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

1-Aminoethane-2-sulfonate USDMF

A 1-Aminoethane-2-sulfonate DMF (Drug Master File) is a document detailing the whole manufacturing process of 1-Aminoethane-2-sulfonate active pharmaceutical ingredient (API) in detail. Different forms of 1-Aminoethane-2-sulfonate DMFs exist exist since differing nations have different regulations, such as 1-Aminoethane-2-sulfonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A 1-Aminoethane-2-sulfonate DMF submitted to regulatory agencies in the US is known as a USDMF. 1-Aminoethane-2-sulfonate USDMF includes data on 1-Aminoethane-2-sulfonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1-Aminoethane-2-sulfonate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of 1-Aminoethane-2-sulfonate suppliers with USDMF on PharmaCompass.

1-Aminoethane-2-sulfonate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The 1-Aminoethane-2-sulfonate Drug Master File in Japan (1-Aminoethane-2-sulfonate JDMF) empowers 1-Aminoethane-2-sulfonate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the 1-Aminoethane-2-sulfonate JDMF during the approval evaluation for pharmaceutical products. At the time of 1-Aminoethane-2-sulfonate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of 1-Aminoethane-2-sulfonate suppliers with JDMF on PharmaCompass.

1-Aminoethane-2-sulfonate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-Aminoethane-2-sulfonate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 1-Aminoethane-2-sulfonate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 1-Aminoethane-2-sulfonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 1-Aminoethane-2-sulfonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-Aminoethane-2-sulfonate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 1-Aminoethane-2-sulfonate suppliers with NDC on PharmaCompass.

1-Aminoethane-2-sulfonate GMP

1-Aminoethane-2-sulfonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of 1-Aminoethane-2-sulfonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1-Aminoethane-2-sulfonate GMP manufacturer or 1-Aminoethane-2-sulfonate GMP API supplier for your needs.

1-Aminoethane-2-sulfonate CoA

A 1-Aminoethane-2-sulfonate CoA (Certificate of Analysis) is a formal document that attests to 1-Aminoethane-2-sulfonate's compliance with 1-Aminoethane-2-sulfonate specifications and serves as a tool for batch-level quality control.

1-Aminoethane-2-sulfonate CoA mostly includes findings from lab analyses of a specific batch. For each 1-Aminoethane-2-sulfonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

1-Aminoethane-2-sulfonate may be tested according to a variety of international standards, such as European Pharmacopoeia (1-Aminoethane-2-sulfonate EP), 1-Aminoethane-2-sulfonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1-Aminoethane-2-sulfonate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty